News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92,994 Results
Type
Article (2626)
Company Profile (7)
Press Release (90361)
Section
Business (39287)
Career Advice (72)
Deals (5671)
Drug Delivery (7)
Drug Development (11082)
Employer Resources (9)
FDA (1980)
Job Trends (2331)
News (55491)
Policy (3217)
Tag
Academia (175)
Accelerated approval (2)
Adcomms (3)
Allergies (14)
Alliances (3106)
ALS (15)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (12)
Approvals (2023)
Artificial intelligence (18)
Autoimmune disease (2)
Bankruptcy (17)
Best Places to Work (2217)
Biosimilars (3)
Biotechnology (7)
Bladder cancer (20)
Brain cancer (2)
Breast cancer (66)
Cancer (407)
Cardiovascular disease (25)
Career advice (59)
Career pathing (3)
CAR-T (18)
Cell therapy (57)
Cervical cancer (5)
Clinical research (9874)
Collaboration (70)
Company closure (1)
Compensation (34)
Complete response letters (1)
COVID-19 (184)
CRISPR (8)
C-suite (10)
Cystic fibrosis (12)
Data (484)
Depression (4)
Diabetes (40)
Diagnostics (864)
Digital health (3)
Diversity, equity & inclusion (3)
Drug discovery (12)
Drug pricing (17)
Duchenne muscular dystrophy (10)
Earnings (34531)
Editorial (1)
Employer resources (7)
Events (11097)
Executive appointments (40)
FDA (2272)
Frontotemporal dementia (3)
Funding (44)
Gene editing (13)
Generative AI (1)
Gene therapy (34)
GLP-1 (95)
Government (393)
Guidances (116)
Healthcare (2655)
Huntington's disease (1)
IgA nephropathy (5)
Immunology and inflammation (11)
Indications (7)
Infectious disease (192)
Inflammatory bowel disease (12)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (6)
Interviews (9)
IPO (4161)
IRA (4)
Job creations (242)
Job search strategy (52)
Kidney cancer (3)
Labor market (9)
Layoffs (39)
Legal (452)
Liver cancer (10)
Lung cancer (74)
Lymphoma (46)
Management (3)
Manufacturing (27)
MASH (20)
Medical device (2116)
Medtech (2116)
Mergers & acquisitions (1571)
Metabolic disorders (110)
Multiple sclerosis (14)
NASH (4)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (256)
NextGen: Class of 2025 (689)
Non-profit (447)
Now hiring (2)
Obesity (53)
Opinion (11)
Ovarian cancer (9)
Pain (4)
Pancreatic cancer (12)
Parkinson's disease (14)
Partnered (3)
Patents (20)
Patient recruitment (16)
Peanut (11)
People (2581)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (2290)
Phase II (3979)
Phase III (4247)
Pipeline (653)
Policy (8)
Postmarket research (449)
Preclinical (677)
Press Release (4)
Prostate cancer (19)
Psychedelics (4)
Radiopharmaceuticals (43)
Rare diseases (52)
Real estate (334)
Recruiting (3)
Regulatory (2644)
Reports (11)
Research institute (194)
Resumes & cover letters (12)
Rett syndrome (1)
RNA editing (1)
RSV (3)
Schizophrenia (14)
Series A (4)
Series B (6)
Sickle cell disease (10)
Special edition (4)
Spinal muscular atrophy (13)
Sponsored (1)
Startups (163)
Stomach cancer (2)
Supply chain (3)
Tariffs (4)
Vaccines (67)
Venture capitalists (2)
Weight loss (28)
Women's health (2)
Worklife (3)
Date
Today (52)
Last 7 days (297)
Last 30 days (638)
Last 365 days (5720)
2025 (2078)
2024 (6273)
2023 (6794)
2022 (10112)
2021 (10882)
2020 (9606)
2019 (6350)
2018 (4801)
2017 (4618)
2016 (3885)
2015 (4797)
2014 (3302)
2013 (1984)
2012 (2216)
2011 (2316)
2010 (2362)
Location
Africa (39)
Alabama (3)
Arizona (20)
Asia (4678)
Australia (516)
California (1043)
Canada (318)
China (74)
Colorado (49)
Connecticut (62)
Delaware (59)
Europe (12170)
Florida (146)
Georgia (38)
Idaho (4)
Illinois (69)
India (2)
Indiana (65)
Japan (45)
Kansas (15)
Kentucky (3)
Louisiana (4)
Maine (33)
Maryland (145)
Massachusetts (822)
Michigan (41)
Minnesota (52)
Missouri (16)
Montana (4)
Nevada (5)
New Hampshire (10)
New Jersey (435)
New York (314)
North Carolina (136)
North Dakota (1)
Northern California (457)
Ohio (21)
Oregon (2)
Pennsylvania (255)
South America (109)
South Carolina (1)
Southern California (455)
Tennessee (8)
Texas (124)
United States (4080)
Utah (37)
Virginia (17)
Washington D.C. (12)
Washington State (109)
Wisconsin (4)
92,994 Results for "34".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemoglobinopathies Market Size to Hit USD 34.76 Billion by 203
February 26, 2025
·
1 min read
Press Releases
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
April 2, 2025
·
3 min read
Press Releases
Ovarian Cancer Drugs Market Size to Hit USD 7.34 Billion by 2034
February 12, 2025
·
1 min read
Press Releases
North America Point of Care Diagnostics Market Size to Hit USD 34.73 Billion by 2033
February 27, 2025
·
1 min read
Pharm Country
Tiziana Receives $3.4 Million in Non-Dilutive Funding
Tiziana Life Sciences, Ltd., a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes announced that it had received non-dilutive funding of $3.4 million and issued a corporate update video available here.
June 28, 2024
·
2 min read
Press Releases
Sciatica Market Size to Reach USD 3.4 Billion by 2035, Impelled by Advancements in Regenerative Therapies
February 19, 2025
·
9 min read
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
Carisma’s second workforce reduction this year likely leaves the company with 44 full-time employees as turns its focus to developing therapies for fibrosis, oncology and autoimmune diseases.
December 10, 2024
·
2 min read
·
Angela Gabriel
Press Releases
Rheumatoid Arthritis Market Size to Reach US$ 34.7 Billion by 2035, Impelled by Obesity and Lifestyle Changes
February 20, 2025
·
11 min read
Press Releases
BioBam Presents OmicsBox 3.4, Including CellKB’s Advanced Cell-Type Annotation
January 14, 2025
·
3 min read
Press Releases
GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements
December 23, 2024
·
2 min read
1 of 9,300
Next
